CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,186,600
- in 2 filings
Net −$1,186,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-01 | Leone Peter Brian VP, Strategy & Program Mgmt | Grant or award | +90,000 | 90,000 | ||
| 2017-01-01 | O'Brien Patrick General Counsel | Grant or award | +145,000 | 175,000 | ||
| 2017-01-01 | Myszkowski Kenneth Allen Chief Financial Officer | Grant or award | +145,000 | 260,689 | ||
| 2017-01-01 | GIVEN BRUCE D Chief Operating Officer | Grant or award | +380,000 | 773,356 | ||
| 2016-12-13 | Anzalone Christopher Richard Chief Executive Officer | Shares withheld for taxes | −300,444 | $1.27 | $382K | 816,789 |
| 2016-10-14 | GIVEN DOUGLAS B Director | Sale | −12,000 | $6.72 | $81K | 70,000 |
| 2016-08-23 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +6,900 | $2.01 | $14K | 122,589 |
| 2016-08-23 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −6,900 | $8.00 | $55K | 115,689 |
| 2016-08-23 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −6,900 | 342,000 | ||
| 2016-08-23 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +6,900 | $2.01 | $14K | 122,589 |
| 2016-08-23 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −6,900 | $8.00 | $55K | 115,689 |
| 2016-08-23 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −6,900 | 342,000 | ||
| 2016-08-22 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +13,100 | $2.01 | $26K | 128,789 |
| 2016-08-22 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −13,100 | $8.00 | $105K | 115,689 |
| 2016-08-22 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −13,100 | 348,900 | ||
| 2016-08-22 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise | +13,100 | $2.01 | $26K | 128,789 |
| 2016-08-22 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −13,100 | $8.00 | $105K | 115,689 |
| 2016-08-22 | Myszkowski Kenneth Allen Chief Financial Officer | Option exercise · Stock Option (right to buy) | −13,100 | 348,900 | ||
| 2016-06-30 | Anzalone Christopher Richard Chief Executive Officer | Option exercise | +15,772 | $5.09 | $80K | 1,117,233 |
| 2016-06-30 | Anzalone Christopher Richard Chief Executive Officer | Option exercise · Common Stock Warrant | −15,772 | 0 |
Page 36 of 38 · 752 trades